In summary, although the specific impact of distinct NMDAR subunits on Top2β activity is still enigmatic, the importance of Top2β for NMDAR-expressing GBM cells has been proven by us through the radio sensitizing effect of Top2β knockdown in the clonogenic survival assay, which identifies Top2β as a feasible therapeutic target in tumor therapy. Here, TOP2B is linked to neoplasm.